We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Cas9-mediated knockout of Ndrg2 enhances the regenerative potential of dendritic cells for wound healing.
- Authors
Henn, Dominic; Zhao, Dehua; Sivaraj, Dharshan; Trotsyuk, Artem; Bonham, Clark Andrew; Fischer, Katharina S.; Kehl, Tim; Fehlmann, Tobias; Greco, Autumn H.; Kussie, Hudson C.; Moortgat Illouz, Sylvia E.; Padmanabhan, Jagannath; Barrera, Janos A.; Kneser, Ulrich; Lenhof, Hans-Peter; Januszyk, Michael; Levi, Benjamin; Keller, Andreas; Longaker, Michael T.; Chen, Kellen
- Abstract
Chronic wounds impose a significant healthcare burden to a broad patient population. Cell-based therapies, while having shown benefits for the treatment of chronic wounds, have not yet achieved widespread adoption into clinical practice. We developed a CRISPR/Cas9 approach to precisely edit murine dendritic cells to enhance their therapeutic potential for healing chronic wounds. Using single-cell RNA sequencing of tolerogenic dendritic cells, we identified N-myc downregulated gene 2 (Ndrg2), which marks a specific population of dendritic cell progenitors, as a promising target for CRISPR knockout. Ndrg2-knockout alters the transcriptomic profile of dendritic cells and preserves an immature cell state with a strong pro-angiogenic and regenerative capacity. We then incorporated our CRISPR-based cell engineering within a therapeutic hydrogel for in vivo cell delivery and developed an effective translational approach for dendritic cell-based immunotherapy that accelerated healing of full-thickness wounds in both non-diabetic and diabetic mouse models. These findings could open the door to future clinical trials using safe gene editing in dendritic cells for treating various types of chronic wounds. Chronic wounds impose a significant burden to a broad patient population. Here, the authors use CRISPR/Cas9 to enhance the regenerative capacity of dendritic cells by knocking out the gene Ndrg2, and show that seeding these engineered dendritic cells on hydrogels constitutes an effective therapy for chronic wounds in diabetic and non-diabetic conditions.
- Subjects
WOUND healing; DENDRITIC cells; CHRONIC wounds &; injuries; CELL populations; GENOME editing; SKIN regeneration; PROGENITOR cells
- Publication
Nature Communications, 2023, Vol 14, Issue 1, p1
- ISSN
2041-1723
- Publication type
Article
- DOI
10.1038/s41467-023-40519-z